Micoy Therapeutics, Inc.
View this filing on EDGAR (filing index, accession 0001665160-24-001489) | All Form C filings by this company on EDGAR
Filing details
| Company | Micoy Therapeutics, Inc. | (Form C, issuer information) |
|---|---|---|
| State | NY | (Form C, issuer information) |
| Platform | StartEngine Primary, LLC | (Form C, issuer information) |
| Filing date | 2024-10-29 | (EDGAR filing index) |
| Date of incorporation | 2024-06-07 | (Form C, issuer information) |
| Employees | 4 | (Form C, issuer information) |
| Security offered | Common Stock | (Form C, offering information) |
| Price per security | $2 | (Form C, offering information) |
| Target amount | $124,000 | (Form C, offering information) |
| Maximum ask | $1,234,994 | (Form C, offering information) |
| Offering deadline | 2025-01-27 | (Form C, offering information) |
| Platform compensation | 7 - 13 percent | (Form C, offering information) |
Financial summary
Figures are as entered by the company in the financial summary on the cover of its Form C. They are self-reported and unaudited, and they are not taken from the financial statements filed as exhibits to the Form C, which we do not read mechanically.
| Item | Most recent fiscal year | Prior fiscal year | Source |
|---|---|---|---|
| Revenue | $0 | $0 | (Form C, financial summary) |
| Cost of goods sold | $0 | $0 | (Form C, financial summary) |
| Net income | -$1,451,848 | -$136,210 | (Form C, financial summary) |
| Taxes paid | $0 | $0 | (Form C, financial summary) |
| Cash and equivalents | $0 | $0 | (Form C, financial summary) |
| Accounts receivable | $0 | $0 | (Form C, financial summary) |
| Total assets | $0 | $0 | (Form C, financial summary) |
| Short-term debt | $0 | $0 | (Form C, financial summary) |
| Long-term debt | $0 | $0 | (Form C, financial summary) |
Mechanical checks that fired
- Related-party language. Related-party language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The phrase can describe routine or unusual arrangements, so read the quoted sentence and the filing. Found in: 0001665160-25-000117.
"C/A 0002041723 XXXXXXXX 020-34986 LIVE false false false true Updated valuation & investment perks disclaimers, disclosed CEO concurrent work, lack of salary, related risks, added details on indebtedness, related-party transactions, updated forward-looking statement disclosures on the campaign page."
- Net loss in both years. Net income is negative in both fiscal years reported in the Form C financial summary.
- Cash below one year of losses. Net loss for the most recent fiscal year is larger than year-end cash, both as reported in the Form C financial summary.
- No revenue. Revenue for the most recent fiscal year is $0 in the Form C financial summary.
- Maximum ask above 10x revenue. The maximum offering amount is more than 10 times the most recent fiscal year revenue (or revenue is $0), per the Form C.
- Platform compensation of 8% or more. The platform compensation stated in the Form C is 8% or more of the offering.
A check means "read this part of the filing closely." It is not a judgment about how the company will do.
Company website as listed in the Form C: https://www.micoytherapeutics.com/
Want the weekly briefing? Subscribe free.